XIIlabLtd Balance Sheet Health

Financial Health criteria checks 6/6

XIIlabLtd has a total shareholder equity of ₩11.1B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩14.0B and ₩2.9B respectively.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ration/a
Cash₩9.56b
Equity₩11.06b
Total liabilities₩2.92b
Total assets₩13.98b

Recent financial health updates

Recent updates

Is XIIlabLtd (KOSDAQ:189330) In A Good Position To Invest In Growth?

Jul 26
Is XIIlabLtd (KOSDAQ:189330) In A Good Position To Invest In Growth?

We're Not Very Worried About XIIlabLtd's (KOSDAQ:189330) Cash Burn Rate

Mar 01
We're Not Very Worried About XIIlabLtd's (KOSDAQ:189330) Cash Burn Rate

Financial Position Analysis

Short Term Liabilities: A189330's short term assets (₩10.3B) exceed its short term liabilities (₩1.4B).

Long Term Liabilities: A189330's short term assets (₩10.3B) exceed its long term liabilities (₩1.5B).


Debt to Equity History and Analysis

Debt Level: A189330 is debt free.

Reducing Debt: A189330 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A189330 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: A189330 has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 52.5% each year.


Discover healthy companies